Long Non-Coding RNA MEG3 in Cellular Stemness

Total Page:16

File Type:pdf, Size:1020Kb

Long Non-Coding RNA MEG3 in Cellular Stemness International Journal of Molecular Sciences Review Long Non-Coding RNA MEG3 in Cellular Stemness Pei-Fang Hsieh 1,2,†, Cheng-Chia Yu 3,4,5,†, Pei-Ming Chu 6 and Pei-Ling Hsieh 6,* 1 Department of Urology, E-Da Hospital, Kaohsiung 82445, Taiwan; [email protected] 2 Department of Medical Laboratory Science and Biotechnology, Chung-Hwa University of Medical Technology, Tainan 71703, Taiwan 3 Institute of Oral Sciences, Chung Shan Medical University, Taichung 40201, Taiwan; [email protected] 4 Department of Dentistry, Chung Shan Medical University Hospital, Taichung 40201, Taiwan 5 School of Dentistry, Chung Shan Medical University, Taichung 40201, Taiwan 6 Department of Anatomy, School of Medicine, China Medical University, Taichung 404333, Taiwan; [email protected] * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: Long non-coding RNAs (lncRNAs) regulate a diverse array of cellular processes at the transcriptional, post-transcriptional, translational, and post-translational levels. Accumulating evidence suggests that lncRNA MEG3 exerts a large repertoire of regulatory functions in cellular stemness. This review focuses on the molecular mechanisms by which lncRNA MEG3 functions as a signal, scaffold, guide, and decoy for multi-lineage differentiation and even cancer progression. The role of MEG3 in various types of stem cells and cancer stem cells is discussed. Here, we provide an overview of the functional versatility of lncRNA MEG3 in modulating pluripotency, differentiation, and cancer stemness. Keywords: long non-coding RNA MEG3; embryonic stem cells; mesenchymal stem cells; cancer stem cells Citation: Hsieh, P.-F.; Yu, C.-C.; Chu, P.-M.; Hsieh, P.-L. Long Non-Coding RNA MEG3 in Cellular Stemness. Int. 1. Introduction J. Mol. Sci. 2021, 22, 5348. https:// doi.org/10.3390/ijms22105348 Maternally expressed gene 3 (MEG3), also known as gene trap locus 2 (Gtl2), was identified by gene trap insertion, and tightly linked to paternally expressed Delta-like 1 Academic Editor: Manching Ku (Dlk1) gene at chromosome 14q32.3 within Dlk1-Dio3 locus [1–3]. The Dlk1 gene encodes a transmembrane protein that contains multiple epidermal growth factor repeats and Received: 27 April 2021 belongs to the Notch signaling family [4]. On the other hand, MEG3 is widely expressed Accepted: 17 May 2021 during development in the paraxial mesoderm, the developing central nervous system, Published: 19 May 2021 and the epithelia of the salivary glands, kidney, and pancreas [1]. Due to the lack of known functional proteins encoded by the small open reading frames of this gene transcript, MEG3 Publisher’s Note: MDPI stays neutral has been considered as a long non-coding RNA (lncRNA) for tumor suppression [5]. with regard to jurisdictional claims in Conventionally, non-coding RNAs can be divided into lncRNAs that have more published maps and institutional affil- than 200 nucleotides in length and the remaining RNAs are recognized as “small” non- iations. coding RNAs, such as microRNAs (miRNAs; ~22 nucleotides), piwiRNAs (piRNAs; ~26–31 nucleotides), or small nucleolar RNAs (snoRNAs; ~60–300 nucleotides). MiRNAs have been known to repress the expression of a target gene with partially complementary binding sites in its 30 untranslated region (30UTR) [6]. As for lncRNAs, diverse func- Copyright: © 2021 by the authors. tions have been discovered to regulate various biological processes, including serving as Licensee MDPI, Basel, Switzerland. scaffolds, molecular signals, guides, or decoys (see review [7]; Figure1). Briefly, some This article is an open access article lncRNAs occur at a certain time and space to integrate diverse stimuli (signal), or they distributed under the terms and may initiate cis- or trans-regulation of gene expression (guide). Additionally, they can conditions of the Creative Commons function as platforms to assemble relevant molecular components to promote or repress Attribution (CC BY) license (https:// gene expression (scaffold). Moreover, lncRNAs may bind to their targets or miRNAs creativecommons.org/licenses/by/ (decoy) to inhibit their action. A similar concept proposes that lncRNAs may be one kind 4.0/). Int. J. Mol. Sci. 2021, 22, 5348. https://doi.org/10.3390/ijms22105348 https://www.mdpi.com/journal/ijms Int. J. Mol. Sci. 2021, 22, x FOR PEER REVIEW 2 of 11 Int. J. Mol. Sci. 2021, 22, 5348 2 of 11 action. A similar concept proposes that lncRNAs may be one kind of competing endoge- nousof competing RNA (ceRNAs) endogenous and serve RNA as (ceRNAs) miRNA sponges and serve to asmodulate miRNA the sponges distribution to modulate of the miRNAsdistribution on oftheir miRNAs targets on via their miRNA targets response via miRNA elements response [8]. elements The interplay [8]. The interplaybetween lncRNAsbetween lncRNAsand miRNAs and miRNAshas been has extensively been extensively studied studied and many and manyreports reports indicate indicate that lncRNAsthat lncRNAs may modulate may modulate the expression the expression of certain of certainmRNAs mRNAs by acting by as acting molecular as molecular decoys anddecoys sequestering and sequestering miRNAs miRNAs to affect tovarious affect variousdisease states. disease states. FigureFigure 1. 1. GeneralGeneral modes modes of of action action of of lncRNAs. lncRNAs. (Adapted (Adapted from from [7]) [7]). AA number number of of studies studies have have suggested suggested that that the the expression expression of of MEG3 MEG3 is is downregulated downregulated inin several several types types of of cancer cancer cells cells [5,9,10], [5,9,10 ],and and DNA DNA methylation methylation has has been been proven proven to toplay play a significanta significant role role in silencing in silencing MEG3 MEG3 in tumors in tumors [11]. [ 11Aside]. Aside fromfrom functioning functioning as a tumor as a tumor sup- pressor,suppressor, emerging emerging evidence evidence suggests suggests that that ME MEG3G3 may may be beinvolved involved in in the the regulation regulation of of stemness.stemness. In In this this review, review, we brieflybriefly summarizedsummarized recent recent studies studies about about the the effect effect of of MEG3 MEG3 on onthe the differentiation differentiation of of embryonic embryonic and and mesenchymal mesenchymal stem stem cells cells as wellas well as theas the aggressiveness aggressive- nessof cancer of cancer stem stem cells. cells. We focusedWe focused on targets/interacting on targets/interacting factors factors and and molecular molecular mechanisms mecha- nismsto provide to provide an insight an insight into the into multiple the multiple functions functions of MEG3 of MEG3 in cellular in cellular stemness. stemness. 2.2. Stem Stem Cells Cells 2.1. Embryonic Stem Cells 2.1. Embryonic Stem Cells During embryonic development and adulthood, MEG3 has been detected in the During embryonic development and adulthood, MEG3 has been detected in the mouse forebrain [12] and corticospinal neurons [13], indicating MEG3 may play a part in mouse forebrain [12] and corticospinal neurons [13], indicating MEG3 may play a part in the maturation of the central nervous system. Besides, MEG3 has been found to be highly the maturation of the central nervous system. Besides, MEG3 has been found to be highly expressed in human embryonic stem cells (hESCs) and to affect their neural differentiation expressedcapacities in [14 human,15]. Embryoid embryonic bodies stem cells derived (hESCs from) and hESCs to affect with their undetectable neural differentiation MEG3 have capacitiesbeen found [14,15]. to exhibit Embryoid unusual bodies morphologies derived alongfrom hESCs with decreased with undetectable expression MEG3 of the neuralhave beenstem found cell marker, to exhibit paired unusual box 6morphologies (PAX6) [14]. Knockdownalong with decreased of MEG3 inexpression hESCs results of the inneu- the raldownregulation stem cell marker, of various paired neuralbox 6 (PAX6) lineage genes.[14]. Knockdown Additionally, of theMEG3 neural in hESCs lineage-like results cells in thederived downregulation from hESCs of with various undetectable neural lineage MEG3 displaygenes. Addition a lower expressionally, the neural of lineage-specific lineage-like cellsmarkers derived and from form hESCs fewer with neurites undetectable [14], suggesting MEG3 thedisplay significance a lower expression of MEG3 in of the lineage- neural specificlineage markers differentiation and form of hESCs.fewer neurites [14], suggesting the significance of MEG3 in the neuralAdditionally, lineage differe MEG3ntiation has of been hESCs. found to interact with polycomb repressive complex-2 (PRC2)Additionally, via jumonji, MEG3 AT rich has interactivebeen found domain to interact 2 (JARID2), with polycomb and facilitate repressive the recruitment complex-2 (PRC2)of PRC2 via on jumonji, chromatin AT rich [15, 16interactive]. The potential domain site 2 (JARID2), where MEG3 and facilitate interacts the with recruitment PRC2 has also been described [17]. JARID2 is a crucial modulator of PRC2 enzymatic activity and is Int. J. Mol. Sci. 2021, 22, 5348 3 of 11 required for the multi-lineage differentiation of ESCs [18]. On the other hand, PRC2 is a histone methyltransferase for epigenetic silencing that works by providing the H3K27me3 repressive epigenetic mark [19]. A large number of lncRNAs have been thought to facilitate the recruitment of PRC2 to the correct chromatin sites [20], and MEG3 is one of them. It serves as a scaffold and bridges the PRC2/JARID2 complex to
Recommended publications
  • The Lncrna Toolkit: Databases and in Silico Tools for Lncrna Analysis
    non-coding RNA Review The lncRNA Toolkit: Databases and In Silico Tools for lncRNA Analysis Holly R. Pinkney † , Brandon M. Wright † and Sarah D. Diermeier * Department of Biochemistry, University of Otago, Dunedin 9016, New Zealand; [email protected] (H.R.P.); [email protected] (B.M.W.) * Correspondence: [email protected] † These authors contributed equally to this work. Received: 29 November 2020; Accepted: 15 December 2020; Published: 16 December 2020 Abstract: Long non-coding RNAs (lncRNAs) are a rapidly expanding field of research, with many new transcripts identified each year. However, only a small subset of lncRNAs has been characterized functionally thus far. To aid investigating the mechanisms of action by which new lncRNAs act, bioinformatic tools and databases are invaluable. Here, we review a selection of computational tools and databases for the in silico analysis of lncRNAs, including tissue-specific expression, protein coding potential, subcellular localization, structural conformation, and interaction partners. The assembled lncRNA toolkit is aimed primarily at experimental researchers as a useful starting point to guide wet-lab experiments, mainly containing multi-functional, user-friendly interfaces. With more and more new lncRNA analysis tools available, it will be essential to provide continuous updates and maintain the availability of key software in the future. Keywords: non-coding RNAs; long non-coding RNAs; databases; computational analysis; bioinformatic prediction software; RNA interactions; coding potential; RNA structure; RNA function 1. Introduction For decades, the human genome was thought to be a desert of ‘junk DNA’ with sporadic oases of transcriptionally active genes, most of them coding for proteins.
    [Show full text]
  • The Long Non-Coding RNA Meg3 Is Dispensable for Hematopoietic Stem Cells
    www.nature.com/scientificreports OPEN The long non-coding RNA Meg3 is dispensable for hematopoietic stem cells Received: 10 October 2018 Pia Sommerkamp1,2,3, Simon Renders1,2, Luisa Ladel1,2, Agnes Hotz-Wagenblatt 4, Accepted: 2 January 2019 Katharina Schönberger1,2,5, Petra Zeisberger1,2, Adriana Przybylla1,2, Markus Sohn1,2, Published: xx xx xxxx Yunli Zhou6, Anne Klibanski6, Nina Cabezas-Wallscheid1,2,5 & Andreas Trumpp1,2 The long non-coding RNA (lncRNA) Maternally Expressed Gene 3 (Meg3) is encoded within the imprinted Dlk1-Meg3 gene locus and is only maternally expressed. Meg3 has been shown to play an important role in the regulation of cellular proliferation and functions as a tumor suppressor in numerous tissues. Meg3 is highly expressed in mouse adult hematopoietic stem cells (HSCs) and strongly down-regulated in early progenitors. To address its functional role in HSCs, we used MxCre to conditionally delete Meg3 in the adult bone marrow of Meg3mat-fox/pat-wt mice. We performed extensive in vitro and in vivo analyses of mice carrying a Meg3 defcient blood system, but neither observed impaired hematopoiesis during homeostatic conditions nor upon serial transplantation. Furthermore, we analyzed VavCre Meg3mat-fox/pat-wt mice, in which Meg3 was deleted in the embryonic hematopoietic system and unexpectedly this did neither generate any hematopoietic defects. In response to interferon-mediated stimulation, Meg3 defcient adult HSCs responded highly similar compared to controls. Taken together, we report the fnding, that the highly expressed imprinted lncRNA Meg3 is dispensable for the function of HSCs during homeostasis and in response to stress mediators as well as for serial reconstitution of the blood system in vivo.
    [Show full text]
  • Dysfunction of the WT1-MEG3 Signaling Promotes AML Leukemogenesis Via P53-Dependent and -Independent Pathways
    OPEN Leukemia (2017) 31, 2543–2551 www.nature.com/leu ORIGINAL ARTICLE Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways YLyu1,2,7, J Lou1,3,7, Y Yang1,2,7, J Feng1,7, Y Hao1, S Huang1, L Yin1,2,JXu1, D Huang1,2,BMa1,3, D Zou1, Y Wang1,2, Y Zhang1, B Zhang3, P Chen4,KYu5, EW-F Lam6, X Wang1, Q Liu1,JYan1,2 and B Jin1 Long non-coding RNAs (lncRNAs) play a pivotal role in tumorigenesis, exemplified by the recent finding that lncRNA maternally expressed gene 3 (MEG3) inhibits tumor growth in a p53-dependent manner. Acute myeloid leukemia (AML) is the most common malignant myeloid disorder in adults, and TP53 mutations or loss are frequently detected in patients with therapy-related AML or AML with complex karyotype. Here, we reveal that MEG3 is significantly downregulated in AML and suppresses leukemogenesis not only in a p53-dependent, but also a p53-independent manner. In addition, MEG3 is proven to be transcriptionally activated by Wilms’ tumor 1 (WT1), dysregulation of which by epigenetic silencing or mutations is causally involved in AML. Therefore MEG3 is identified as a novel target of the WT1 molecule. Ten–eleven translocation-2 (TET2) mutations frequently occur in AML and significantly promote leukemogenesis of this disorder. In our study, TET2, acting as a cofactor of WT1, increases MEG3 expression. Taken together, our work demonstrates that TET2 dysregulated WT1-MEG3 axis significantly promotes AML leukemogenesis, paving a new avenue for diagnosis and treatment of AML patients.
    [Show full text]
  • The Interaction Between P53 and Mdm2 Is Independent of MEG3–P53 Association
    bioRxiv preprint doi: https://doi.org/10.1101/857912; this version posted November 29, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. The interaction between p53 and Mdm2 is independent of MEG3–p53 association Nicholas C. Bauera, Anli Yangb,†,§, Xin Wangb,†,‖, Yunli Zhoub, Anne Klibanskib,‡,¶, Roy J. Sobermana,*,‡ a Division of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129 b Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 * To whom correspondence should be addressed. Tel: +1 617-455-2003; Email: [email protected] † These authors contributed equally to the work ‡ These authors contributed equally to the work § Current affiliation: Department of Histology and Embryology, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China ‖ Current affiliation: Department of Breast Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China ¶ Current affiliation: Partners Healthcare, Somerville, MA bioRxiv preprint doi: https://doi.org/10.1101/857912; this version posted November 29, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Bauer et al. – Page 2 ABSTRACT The ability of the long noncoding RNA MEG3 to suppress cell proliferation led to its recognition as a tumor suppressor.
    [Show full text]
  • Epigenetic Regulation of the Dlk1-Meg3 Imprinted Locus in Human Islets
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2016 Epigenetic Regulation of the Dlk1-Meg3 Imprinted Locus in Human Islets Vasumathi Kameswaran University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Cell Biology Commons, Genetics Commons, and the Molecular Biology Commons Recommended Citation Kameswaran, Vasumathi, "Epigenetic Regulation of the Dlk1-Meg3 Imprinted Locus in Human Islets" (2016). Publicly Accessible Penn Dissertations. 1798. https://repository.upenn.edu/edissertations/1798 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1798 For more information, please contact [email protected]. Epigenetic Regulation of the Dlk1-Meg3 Imprinted Locus in Human Islets Abstract Type 2 diabetes mellitus (T2DM) is a complex metabolic disease characterized by inadequate insulin secretion by the pancreatic β-cell in response to increased blood glucose levels. Despite compelling evidence that T2DM has a high rate of familial aggregation, known genetic risk variants account for less than 10% of the observed heritability. Consequently, post-transcriptional regulators of gene expression, including microRNAs and other noncoding RNAs, have been implicated in the etiology of T2DM, in part due to their ability to simultaneously regulate the expression of hundreds of targets. To determine if microRNAs are involved in the pathogenesis of human T2DM, I sequenced the small RNAs of human islets from diabetic and non-diabetic organ donors. From this screen, I identified the maternally-expressed genes in the imprinted DLK1-MEG3 locus as highly- and specifically-expressed in human β-cells, but repressed in T2DM islets. Repression of this noncoding transcript was strongly correlated with hyper-methylation of the promoter that drives transcription of all the maternal noncoding RNAs including the long noncoding RNA MEG3, several microRNAs and snoRNAs.
    [Show full text]
  • Structure-Functional Studies on Lncrna MEG3 Tina Uroda
    Structure-functional studies on lncRNA MEG3 Tina Uroda To cite this version: Tina Uroda. Structure-functional studies on lncRNA MEG3. Biomolecules [q-bio.BM]. Université Grenoble Alpes, 2019. English. NNT : 2019GREAV014. tel-02569435 HAL Id: tel-02569435 https://tel.archives-ouvertes.fr/tel-02569435 Submitted on 11 May 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THÈSE Pour obtenir le grade de DOCTEUR DE LA COMMUNAUTÉ UNIVERSITÉ GRENOBLE ALPES Spécialité : Biologie Structurale et Nanobiologie Arrêté ministériel : 25 mai 2016 Présentée par Tina URODA Thèse dirigée par Marco MARCIA préparée au sein du Laboratoire laboratoire européen de biologie moléculaire dans l'École Doctorale Chimie et Sciences du Vivant Caractérisation structurale et fonctionnelle de l'ARN long non codant MEG3 Structure-functional studies on lncRNA MEG3 Thèse soutenue publiquement le 9 mai 2019, devant le jury composé de : Monsieur MARCO MARCIA DIRECTEUR DE RECHERCHE, EMBL GRENOBLE, Directeur de thèse Monsieur ALBERTO INGA PROFESSEUR, UNIVERSITE DE TRENTE - ITALIE, Rapporteur Madame MAITE HUARTE DIRECTRICE DE RECHERCHE, UNIVERSITE DE NAVARRE- PAMPELUNE-ESPAGNE, Rapporteur Monsieur CLAIRE VOURC'H PROFESSEUR, UNIVERSITE GRENOBLE ALPES, Président Madame REINI F. LUCO DIRECTRICE DE RECHERCHE, CNRS DELEGATION LANGUEDOC- ROUSSILLON, Examinateur Monsieur JANOSCH HENNIG DIRECTEUR DE RECHERCHE, EMBL HEIDELBERG ALLEMAGNE, Examinateur Table of Contents Table of Contents ...........................................................................................................................
    [Show full text]
  • Imprinted Genes and Multiple Sclerosis: What Do We Know?
    International Journal of Molecular Sciences Review Imprinted Genes and Multiple Sclerosis: What Do We Know? Natalia Baulina 1,2,* , Ivan Kiselev 1 and Olga Favorova 1,2 1 Institute of Translational Medicine, Pirogov Russian National Research Medical University, 117997 Moscow, Russia; [email protected] (I.K.); [email protected] (O.F.) 2 Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, 117997 Moscow, Russia * Correspondence: [email protected] Abstract: Multiple sclerosis (MS) is a chronic autoimmune neurodegenerative disease of the central nervous system that arises from interplay between non-genetic and genetic risk factors. The epige- netics functions as a link between these factors, affecting gene expression in response to external influence, and therefore should be extensively studied to improve the knowledge of MS molecular mechanisms. Among others, the epigenetic mechanisms underlie the establishment of parent-of- origin effects that appear as phenotypic differences depending on whether the allele was inherited from the mother or father. The most well described manifestation of parent-of-origin effects is genomic imprinting that causes monoallelic gene expression. It becomes more obvious that dis- turbances in imprinted genes at the least affecting their expression do occur in MS and may be involved in its pathogenesis. In this review we will focus on the potential role of imprinted genes in MS pathogenesis. Keywords: multiple sclerosis; parent-of-origin effect; genomic imprinting; DLK1-DIO3 locus; miRNA Citation: Baulina, N.; Kiselev, I.; 1. Introduction Favorova, O. Imprinted Genes and Multiple Sclerosis: What Do We Multiple sclerosis (MS) is a chronic autoimmune and neurodegenerative disease of Know? Int.
    [Show full text]
  • Cancer Cells Retrace a Stepwise Differentiation Program During Malignant Progression
    Author Manuscript Published OnlineFirst on April 28, 2021; DOI: 10.1158/2159-8290.CD-20-1637 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Cancer cells retrace a stepwise differentiation program during malignant progression Sadegh Saghafinia 1,2,3,#, Krisztian Homicsko 1, Annunziata Di Domenico 4, Stephan Wullschleger 1,+, Aurel Perren 4, Ilaria Marinoni 4, Giovanni Ciriello 2,3, Iacovos P. Michael 1,$,#,*, and Douglas Hanahan 1,5,* 1 Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland 2 Department of Computational Biology, University of Lausanne (UNIL), Lausanne, Switzerland 3 Swiss Institute of Bioinformatics (SIB) 4 Institute of Pathology, University of Bern, Bern, Switzerland 5 Lausanne Branch, Ludwig Institute for Cancer Research, Lausanne, Switzerland + Current address: Molecular Partners AG, Zurich, Switzerland $ Current address: Biological Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada # These authors contributed equally * Corresponding authors: [email protected], [email protected] Running Title Retracing stepwise differentiation during tumor progression Keywords Pancreatic Neuroendocrine tumor, Dedifferentiation, Cancer plasticity, Tumor heterogeneity, Metastasis, miRNA-181, Hmgb3, Meis2 Corresponding Authors contact details: Iacovos P. Michael, Sunnybrook Research Institute, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5, Canada | Phone: 416-480-6100x3354
    [Show full text]
  • Epigenetic Detection of Human Chromosome 14 Uniparental Disomy
    HUMAN MUTATION 22:92^97 (2003) METHODS Epigenetic Detection of Human Chromosome 14 Uniparental Disomy S.K. Murphy,1* A.A. Wylie,1,2 K.J. Coveler,3 P.D. Cotter,4 P.R. Papenhausen,5 V.R. Sutton,3 L.G. Shaffer,3 and R.L. Jirtle1 1Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina; 2AstraZeneca Pharmaceuticals, Ltd., Alderley Edge, Cheshire, UK; 3Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas; 4Division of Medical Genetics, Children’s Hospital Oakland, Oakland, California; 5Department of Cytogenetics, LabCorp Inc., Research Triangle Park, North Carolina Communicated by Haig H. Kazazian The recent demonstration of genomic imprinting of DLK1 and MEG3 on human chromosome 14q32 indicates that these genes might contribute to the discordant phenotypes associated with uniparental disomy (UPD) of chromosome 14. Regulation of imprinted expression of DLK1 and MEG3 involves a differentially methylated region (DMR) that encompasses the MEG3 promoter. We exploited the normal differential methylation of the DLK1/MEG3 region to develop a rapid diagnostic PCR assay based upon an individual’s epigenetic profile. We used methylation-specific multiplex PCR in a retrospective analysis to amplify divergent lengths of the methylated and unmethylated MEG3 DMR in a single reaction and accurately identified normal, maternal UPD14, and paternal UPD14 in bisulfite converted DNA samples. This approach, which is based solely on differential epigenetic profiles, may be generally applicable for rapidly and economically screening for other imprinting defects associated with uniparental disomy, determining loss of heterozygosity of imprinted tumor suppressor genes, and identifying gene-specific hypermethylation events associated with neoplastic progression.
    [Show full text]
  • Maternally Expressed Gene 3, an Imprinted Noncoding RNA Gene, Is Associated with Meningioma Pathogenesis and Progression
    Published OnlineFirst February 23, 2010; DOI: 10.1158/0008-5472.CAN-09-3885 Published Online First on February 23, 2010 as 10.1158/0008-5472.CAN-09-3885 Molecular and Cellular Pathobiology Cancer Research Maternally Expressed Gene 3, an Imprinted Noncoding RNA Gene, Is Associated with Meningioma Pathogenesis and Progression Xun Zhang1, Roger Gejman1,2, Ali Mahta1, Ying Zhong1, Kimberley A. Rice1, Yunli Zhou1, Pornsuk Cheunsuchon1,2, David N. Louis2, and Anne Klibanski1 Abstract Meningiomas are common tumors, representing 15% to 25% of all central nervous system tumors. NF2 gene inactivation on chromosome 22 has been shown as an early event in tumorigenesis; however, few factors un- derlying tumor growth and progression have been identified. The chromosomal abnormalities of 14q32 are often associated with meningioma pathogenesis and progression; therefore, it has been proposed that an as yet unidentified tumor suppressor is present at this locus. Maternally expressed gene 3 (MEG3) is an imprinted gene located at 14q32 which encodes a noncoding RNA with an antiproliferative function. We found that MEG3 mRNA is highly expressed in normal arachnoidal cells. However, MEG3 is not expressed in the majority of human meningiomas or the human meningioma cell lines IOMM-Lee and CH157-MN. There is a strong association between loss of MEG3 expression and tumor grade. Allelic loss at the MEG3 locus is also observed in meningiomas, with increasing prevalence in higher grade tumors. In addition, there is an increase in CpG methylation within the promoter and the imprinting control region of MEG3 gene in meningiomas. Function- ally, MEG3 suppresses DNA synthesis in both IOMM-Lee and CH157-MN cells by ∼60% in bromodeoxyuridine incorporation assays.
    [Show full text]
  • Transcriptomic Analysis of Mrna-Lncrna-Mirna Interactions
    www.nature.com/scientificreports OPEN Transcriptomic Analysis of mRNA- lncRNA-miRNA Interactions in Hepatocellular Carcinoma Xia Tang1, Delong Feng2, Min Li3, Jinxue Zhou4, Xiaoyuan Li5, Dachun Zhao6, Bingtao Hao2,7, Dewei Li8 & Keyue Ding1,9* Fully elucidating the molecular mechanisms of non-coding RNAs (ncRNAs), including micro RNAs (miRNAs) and long non-coding RNAs (lncRNAs), underlying hepatocarcinogenesis is challenging. We characterized the expression profles of ncRNAs and constructed a regulatory mRNA-lncRNA-miRNA (MLMI) network based on transcriptome sequencing (RNA-seq) of hepatocellular carcinoma (HCC, n = 9) patients. Of the identifed miRNAs (n = 203) and lncRNAs (n = 1,090), we found 16 signifcantly diferentially expressed (DE) miRNAs and three DE lncRNAs. The DE RNAs were highly enriched in 21 functional pathways implicated in HCC (p < 0.05), including p53, MAPK, and NAFLD signaling. Potential pairwise interactions between DE ncRNAs and mRNAs were fully characterized using in silico prediction and experimentally-validated evidence. We for the frst time constructed a MLMI network of reciprocal interactions for 16 miRNAs, three lncRNAs, and 253 mRNAs in HCC. The predominant role of MEG3 in the MLMI network was validated by its overexpression in vitro that the expression levels of a proportion of MEG3-targeted miRNAs and mRNAs was changed signifcantly. Our results suggested that the comprehensive MLMI network synergistically modulated carcinogenesis, and the crosstalk of the network provides a new avenue to accurately describe the molecular mechanisms of hepatocarcinogenesis. Hepatocellular carcinoma (HCC) is the third cause of cancer mortality worldwide1. Chronic liver infection due to hepatitis B or C virus (HBV or HCV) infection is one of the most important risk factors for HCC1.
    [Show full text]
  • The Role of Lncrna in the Development of Tumors, Including Breast Cancer
    International Journal of Molecular Sciences Review The Role of lncRNA in the Development of Tumors, including Breast Cancer Beata Smolarz 1,* , Anna Zadrozna-Nowak˙ 2 and Hanna Romanowicz 1 1 Laboratory of Cancer Genetics, Department of Pathology, Polish Mother’s Memorial Hospital Research Institute, Rzgowska 281/289, 93-338 Lodz, Poland; [email protected] 2 Department of Chemotherapy, Copernicus Memorial Hospital, Medical University of Lodz, 93-513 Lodz, Poland; [email protected] * Correspondence: [email protected] Abstract: Long noncoding RNAs (lncRNAs) are the largest groups of ribonucleic acids, but, despite the increasing amount of literature data, the least understood. Given the involvement of lncRNA in basic cellular processes, especially in the regulation of transcription, the role of these noncoding molecules seems to be of great importance for the proper functioning of the organism. Studies have shown a relationship between disturbed lncRNA expression and the pathogenesis of many diseases, including cancer. The present article presents a detailed review of the latest reports and data regarding the importance of lncRNA in the development of cancers, including breast carcinoma. Keywords: tumors; breast cancer; lncRNA; expression 1. lncRNA—History Citation: Smolarz, B.; Zadrozna-Nowak,˙ A.; Romanowicz, The history of lncRNA, or long noncoding RNA, dates back to the early 21st century. H. The Role of lncRNA in the In 2001, two groundbreaking works were published—the first in Nature and the second in Development of Tumors, including Science—which presented 96% [1] and 100% of the human genome, respectively [2]. The Breast Cancer. Int. J. Mol. Sci. 2021, 22, final sequence of the human genome was released in 2003.
    [Show full text]